tiprankstipranks
HAVN Life Sciences (HAVLF)
OTHER OTC:HAVLF

HAVN Life Sciences (HAVLF) Stock Price & Analysis

30 Followers

HAVLF Stock Chart & Stats

Day’s Range$0 - $0
52-Week Range<$0.01 - $0.15
Previous Close$0.02
Volume1.00
Average Volume (3M)9.08K
Market Cap
$561.39K
Enterprise Value$572.09K
Total Cash (Recent Filing)C$13.99K
Total Debt (Recent Filing)C$26.23K
Price to Earnings (P/E)>-0.1
Beta0.34
Sep 20, 2024
EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-2.94
Shares Outstanding14,738,611
10 Day Avg. Volume178
30 Day Avg. Volume9,077
Standard Deviation0.70
R-Squared0.00709
Alpha-0.05
Financial Highlights & Ratios
Price to Book (P/B)0.53
Price to Sales (P/S)5.54
Price to Cash Flow (P/CF)0.40
P/FCF Ratio0.40
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0

Financials

Annual

Options Prices

Currently, No data available
---

Ownership Overview

39.97%0.00%0.00%60.03%
39.97%
Insiders
0.00% Other Institutional Investors
60.03% Public Companies and
Individual Investors

HAVLF FAQ

What was HAVN Life Sciences’s price range in the past 12 months?
HAVN Life Sciences lowest stock price was <$0.01 and its highest was $0.15 in the past 12 months.
    What is HAVN Life Sciences’s market cap?
    Currently, no data Available
    When is HAVN Life Sciences’s upcoming earnings report date?
    HAVN Life Sciences’s upcoming earnings report date is Sep 20, 2024 which is in 148 days.
      How were HAVN Life Sciences’s earnings last quarter?
      Currently, no data Available
      Is HAVN Life Sciences overvalued?
      According to Wall Street analysts HAVN Life Sciences’s price is currently Overvalued. Get more investment ideas with TipRanks Premium
        Does HAVN Life Sciences pay dividends?
        HAVN Life Sciences does not currently pay dividends.
        What is HAVN Life Sciences’s EPS estimate?
        HAVN Life Sciences’s EPS estimate for its next earnings report is not yet available.
        How many shares outstanding does HAVN Life Sciences have?
        HAVN Life Sciences has 25,646,020 shares outstanding.
          What happened to HAVN Life Sciences’s price movement after its last earnings report?
          Currently, no data Available
          Which hedge fund is a major shareholder of HAVN Life Sciences?
          Currently, no hedge funds are holding shares in HAVLF
          ---

          HAVN Life Sciences Stock Smart Score

          Company Description

          HAVN Life Sciences

          HAVN Life Sciences Inc is a biotechnology company engaged in the business of the research and development of psycho-pharmacological products, including the formulation of standardized psychoactive compounds derived from fungi. The products of the company will help to improve mental health and human performance.
          ---
          Similar Stocks
          Company
          Price & Change
          Follow
          COMPASS Pathways
          Cybin
          Tilray
          Canopy Growth
          Popular Stocks
          ---
          What's Included in PREMIUM?
          Make informed decisions based on Top Analysts' activity
          Know what industry insiders are buying
          Get actionable alerts from top Wall Street Analysts
          Find out before anyone else which stock is going to shoot up
          Get powerful stock screeners & detailed portfolio analysis